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A 10-year-old captive male Siberian tiger (Panthera tigris altaica) presented with acute onset collapse, vomit-
ing and dyspnoea, preceded by a 6-month period of progressive muscle wasting. Following humane destruc-
tion, post-mortem examination revealed a large multilobulated mass in the cranial mediastinum, which was
diagnosed as a T-lymphocyte-rich thymoma with the aid of immunohistochemistry. Retrospective serology
for acetylcholine receptor antibodies (titre 3.90 nmol/l) confirmed a diagnosis of thymoma-associated myas-
thenia gravis. Thymomas are reported rarely in wild carnivores, but when detected they appear to be similar
in morphology to those seen in domestic carnivores and may also be accompanied by paraneoplastic syn-
dromes. The clinical signs of myasthenia gravis in the tiger were consistent with those reported in cats
and dogs and the condition is proposed as an important differential diagnosis for generalized weakness in
captive Felidae.
 2013 The Authors. Published by Elsevier Ltd. All rights reserved.Keywords: myasthenia gravis; Panthera tigris altaica; Siberian tiger; thymomaThymoma is an uncommon neoplasm of the cranial
mediastinum, composed of neoplastic thymic epithe-
lium usually accompanied by various degrees of lym-
phocytic infiltration (Jacobs et al., 2008). In people,
thymomas are organised into five categories (A, AB,
B1, B2 and B3) using a World Health Organization
(WHO) classification system that aims to predict
the clinical behaviour and prognosis of this neoplasm
(Travis et al., 2004; Suster and Moran, 2006). In
animals thymomas are classified on the basis of the
predominant cell population within the mass and
may be lymphocyte predominant, epithelial cell
predominant or of an intermediate lympho-
epithelial subtype. Immunohistochemistry (IHC) is
often required to confirm the presence of neoplastic
thymic epithelial cells in lymphocyte-rich thymomass an open-access article distributed under the terms of the Creative
ns Attribution-NonCommercial-No Derivative Works License,
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x.doi.org/10.1016/j.jcpa.2013.11.204and to differentiate thymomas from mediastinal lym-
phomas, which occur more commonly in most ani-
mals (Jacobs et al., 2008). Spontaneously-occurring
thymomas have been reported in a range of domestic
animals including dogs and cats (Day, 2008), cattle
(Ecco et al., 2006), rabbits (Kunzel et al., 2012) and
goats (Hadlow, 1978) as well as in various laboratory
primates and rodents (Walsh and Poteracki, 1994;
Brandes et al., 2004; Schwartz et al., 2011).
However, in wildlife species reports of thymomas are
scarce. Here we describe the morphological and
paraneoplastic features of a thymoma diagnosed at
post-mortem examination in a captive Siberian tiger
(Panthera tigris altaica).
A 10-year-old, male neutered Siberian tiger, born
and housed at the Zoological Society of London
(ZSL) Whipsnade collection, presented on 27th
October 2011 to resident veterinary staff in sternal re-
cumbency with acute onset vomiting, depression and
a right-sided head tilt. The tiger had been treated for
progressive muscle wasting and suspected renal insuf-
ficiency with oral benazepril hydrochloride (0.5 mg/ 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
346 K. Allan et al.kg q24h; Fortekor Flavour 20 mg for dogs; Novartis,
Camberley, Surrey, UK) for 6 months prior to acute
presentation. Following collapse, general anaesthesia
was induced to facilitate clinical examination using
480 mg ketamine (ketamine 1 g powder for reconsti-
tution; Kyron Laboratories, Benrose, Johannesburg,
South Africa) and 6 mg medetomidine (Zalopine
10 mg/ml; Orion Pharma, Newbury, Berkshire,
UK) administered by remote intramuscular injec-
tion. Endotracheal intubation was performed and
anaesthesia was maintained with oxygen and isoflur-
ane (Isoflurane-Vet 100% w/w inhalation vapour;
Merial Animal Health, Harlow, Essex, UK). On
physical examination, the tiger was tachycardic
with poor peripheral circulation. An abnormal respi-
ratory pattern, characterized by inspiratory stridor
accompanied by irregular periods of apnoea, was
observed and intermittent positive pressure ventila-
tion was initiated. Venous blood samples were ob-
tained, but standard haematological and
biochemical parameters were within published refer-
ence values for this species (ISIS, 2002). On welfare
grounds, the tiger was humanely destroyed and sub-
mitted for pathological examination.
Post-mortem examination revealed a large, 1.5 kg,
18  15  10 cm, well-demarcated, multilobulated,
mediastinal mass within the cranial thorax (Fig. 1).
The pleural and peritoneal cavities both contained
small amounts of serosanguineous fluid. There was
generalized depletion of subcutaneous fat stores in
addition to moderate atrophy of skeletal muscle
over the hindquarters.
Representative tissue samples were collected and
fixed in 10% neutral buffered formalin and submittedFig. 1. Intrathoracicmass after reflection of the ventral thorax and
sternum. Awell-demarcated, multilobulatedmass expands
the cranial mediastinum. Bar, 3 cm.to Abbey Veterinary Services, Newton Abbott, UK,
for examination. Tissue samples were processed
routinely and sections (4 mm) were stained with hae-
matoxylin and eosin (HE). Subsequently, samples
from the mediastinal mass were transported to the
University of GlasgowVeterinary Diagnostic Services
for IHC. Sections were labelled with a panel of pri-
mary antibodies including mouse anti-vimentin
(Clone V9, Dako, Ely, UK; dilution 1 in 50), which
did not require antigen retrieval, and mouse anti-
human cytokeratin (Clone MNF116, Dako; dilution
1 in 100), which required enzymatic antigen retrieval
with proteinase K. Heat-induced epitope retrieval us-
ing sodium citrate buffer (pH 6.0) was required for
the following antibodies: mouse anti-human
CD79acy (Clone HM57, Dako; dilution 1 in 100);
mouse anti-human B cell-specific activator protein
(Clone DAK-Pax 5, Dako; dilution 1 in 100) and rab-
bit anti-human CD3 (Dako, dilution 1 in 100). IHC
was performed using a Dako Autostainer. Tissue sec-
tions were also stained with Astra blue (Sigmae
Aldrich, Gillingham, UK) as previously described
(Blaies and Williams, 1981).
Microscopically, the mass was a large, multilobu-
lated, densely cellular and poorly demarcated
tumour, composed of abundant, densely packed and
well-differentiated small to medium sized lympho-
cytes arranged in sheets that frequently obscured a
less numerous background population of polygonal
to stellate neoplastic cells. The neoplastic cells were
arranged in variably packed cords and supported by
a well-vascularized collagenous and adipose connec-
tive tissue stoma. The neoplastic cells were large
(15e20 mm in diameter) and poorly differentiated
with moderate amounts of finely granular eosino-
philic cytoplasm and indistinct cell borders (Fig. 2).
The nuclei were oval, centrally located, often with a
single prominent magenta nucleolus and peripheral-
ized chromatin. There was moderate anisocytosis
and anisokaryosis, but mitoses were rare, with <1
mitotic figure per 10 high-power (400) fields.
Throughout the tumour were numerous, multifocal
aggregates of eosinophils admixed with smaller
numbers of plasma cells and mast cells.
IHC demonstrated strong labelling of stellate
neoplastic cells with cytokeratin-specific antibodies
(Fig. 3). The predominant population of lymphocytes
was CD3+ (Fig. 4), but showed little evidence of
labelling with either CD79 or Pax-5 antibodies.
Rare scattered mast cells were identified with Astra
blue staining. There was no evidence of immunolab-
elling of any cells with vimentin-specific antibodies.
Followingmicroscopical examination of tissue sam-
ples, serumwas submitted to the Comparative Neuro-
muscular Laboratory (Department of Pathology,
Fig. 2. The mass is composed of sheets of small to medium sized
lymphocytes that obscure a background population of
polygonal to stellate neoplastic cells. HE.
Fig. 4. Lymphocytes demonstrate ubiquitous immunoreactivity
with rabbit anti-human CD3 antibodies. IHC.
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nia, USA) for detection of acetylcholine receptor an-
tibodies (AChR). A titre of 3.90 nmol/l was measured
by immunoprecipitation radioassay (normal refer-
ence levels; dog<0.6 nmol/l; cat<0.3 nmol/l). Retro-
spective serological assays for feline
immunodeficiency virus and feline leukaemia virus
were negative.
On the basis of the histological appearance and
observed pattern of immunoreactivity, the tumour
was diagnosed as a T-lymphocyte predominant thy-
moma. Although CD3+ T lymphocytes formed a
large component of the tissue, the epithelial charac-
teristics of the neoplastic cells confirmed a thymic
origin. Despite good labelling with most of the IHC
antibody panel, as well as previous reports in the liter-
ature of successful vimentin-immunolabelling of tigerFig. 3. Stellate neoplastic cells demonstrate strong labelling with
mouse anti-human cytokeratin antibodies. IHC.tissues (Scudamore and Meredith, 2001; Kang et al.,
2006), anti-vimentin antibodies failed to react with
any mesenchymal cells in these sections. Modification
of the labelling methodology, such as extending incu-
bation times or increasing antibody concentrations,
may be required to further optimize the technique
(Ramos-Vara et al., 2008).
To the authors’ knowledge, this is the first report
describing the morphological features of a thymoma
in a Siberian tiger. In the veterinary literature, there
is one report of a thymic mass in an aged female tiger
with myasthenia gravis, but the morphology of this
mass was not described (Wallace and Teare, 1994).
Reports of thymoma in other captive wildlife species
are limited to an asymptomatic thymoma in an Afri-
can spot-necked otter (Lutra maculicollus), which was
detected at routine health examination and subse-
quently removed, and a single report of thymoma-
associated myasthenia gravis in an adult female polar
bear (Ursus maritinus) (Kenny et al., 2004; Pye et al.,
2010). In these two animals, the lesions were
predominately composed of spindle-shaped epithelial
cell populations with varying degrees of lymphocytic
infiltration.
In animals, thymic epithelial tumours show vari-
able tendencies to cause clinical disease in different
livestock and companion animal species. Clinically
significant lymphocyte-rich thymomas are most
frequently reported in the dog, but in small ruminant
species, such as the goat and sheep, lymphoid thymo-
mas are typically incidental findings at necropsy ex-
amination (Hadlow, 1978; Valli and Gentry, 2007).
Although the signs of a space-occupying mediastinal
mass, such as dyspnoea, cardiovascular impairment
and exophthalmos, may occur in any species (Valli
and Gentry, 2007; Day, 2008; Kunzel et al., 2012),
the most severe clinical signs in people and domestic
348 K. Allan et al.carnivores are usually associated with the presence of
thymoma-associated paraneoplastic disease, most
commonly myasthenia gravis.
Myasthenia gravis is an autoimmune disorder that
causes focal or generalized muscle weakness as a
consequence of autoantibody-mediated destruction
of acetylcholine receptors within neuromuscular syn-
apses (Shelton, 2002). In people, myasthenia gravis is
diagnosed in 30e44% of cases of thymoma and its
occurrence is usually associated with widespread infil-
tration of the thymoma with numerous T lympho-
cytes in various stages of maturation (thymopoiesis)
(Marx et al., 2010). In domestic animals, the syn-
drome is less well described, but paraneoplastic myas-
thenia gravis can be seen at a similar frequency in
dogs with thymoma (Aronsohn et al., 1984; Jacobs
et al., 2008) and the presence of follicle-like aggregates
of lymphocytes within canine and feline thymomas is
thought to be positively associated with its occurrence
(Valli and Gentry, 2007).
In human patients, myasthenia gravis is character-
ized by abnormal limb muscle fatigue and weakness,
which worsens with exercise. Localized symptoms,
such as oculomotor weakness or difficulties chewing
and swallowing, may also be seen (Allen and Lueck,
2002). Clinical signs in affected dogs also range from
localized deficits, such as dysphagia and regurgita-
tion, to generalized muscle weakness or acute, fulmi-
nating disease with rapid onset tetraparesis and
respiratory failure (Dewey et al., 1997; Shelton et al.,
2000; Shelton, 2002). In cats, generalized muscle
weakness is the most common presentation (Shelton
et al., 2000).
In exotic Felidae and other species, diagnosis of
myasthenia gravis relies on demonstrating circulating
AChR antibodies with cross-reactivity to fetal canine
and feline muscle antigen (Shelton, 2002; Kenny
et al., 2004). Demonstration of AChR antibodies
using the immunoprecipitation radioassay has
previously been used to diagnose myasthenia gravis
in a captive Siberian tiger from Milwaukee Country
Zoo, using antibody titres from three healthy tigers
(<0.1 nmol/l) to provide a baseline value for this
species (Wallace and Teare, 1994). Cross-reacting
AChR antibodies were substantially elevated in our
case in comparison to this baseline, as well as to refer-
ence values used for domestic carnivores. Clinical
signs described in Siberian tigers with elevated
AChR antibody levels are consistent with those re-
ported in dogs and cats with myasthenia gravis. In
particular, similarities were noted between the severe
fulminating form of myasthenia gravis in dogs and the
acute and severe nature of the end-stage disease pre-
sentation in this case (Dewey et al., 1997; King and
Vite, 1998; Kenny et al., 2004).In conclusion, this paper presents the first morpho-
logical description of a T-lymphocyte-rich thymoma
in a Siberian tiger, as well as the second laboratory-
confirmed case report of myasthenia gravis in this spe-
cies. The histological and paraneoplastic features of
this tumour are consistent with thymomas in domestic
carnivores and good cross-reactivity of tiger AChR
antibodies with feline and canine antigens is demon-
strated. Thymoma-associated myasthenia gravis
should be considered as an important differential in
captive tigers and other carnivores presenting with
generalized or focal muscle weakness, dysphagia
and regurgitation or with acute collapse and respira-
tory compromise.Acknowledgments
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